Buprenorphine and Naloxone Combination Study - 10
| Status: | Completed |
|---|---|
| Conditions: | Psychiatric, Gastrointestinal |
| Therapuetic Areas: | Gastroenterology, Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 21 - 50 |
| Updated: | 1/13/2017 |
| Start Date: | November 1996 |
PK0496 Pharmacokinetics of Buprenorphine
The purpose of this study is to examine pharmacokinetics and dose proportionality of
sublingual tablets containing varying doses of buprenorphine and naloxone.
sublingual tablets containing varying doses of buprenorphine and naloxone.
The objective of this study is to examine pharmacokinetics and dose proportionality of
sublingual tablets containing varying doses of buprenorphine and naloxone.
sublingual tablets containing varying doses of buprenorphine and naloxone.
Inclusion Criteria:
Male/Female between the ages of 21 and 45. Within 15% of ideal body weight. No oral
pathology that would interfere with the sublingual absorption of the medication.
Experienced in the use of opiates but not dependent.
Exclusion Criteria:
LFT's exceeding than 3x's normal. History of seizure. Opiate dependent.
We found this trial at
1
site
Click here to add this to my saved trials
